Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
Add more filters










Publication year range
1.
Dis Aquat Organ ; 131(1): 73-78, 2018 10 16.
Article in English | MEDLINE | ID: mdl-30324916

ABSTRACT

The emerging infectious disease chytridiomycosis, caused by the fungus Batrachochytrium dendrobatidis, is a major driver pushing many amphibian species to the brink of extinction. Substantial efforts to develop effective protocols that use antifungal drugs have had notable success. Here, we used the antifungal agents itraconazole and thiophanate-methyl, singly and in combination, in an attempt to treat common midwife toad Alytes obstetricans larvae naturally infected with the globalized hypervirulent lineage of B. dendrobatidis. Despite the successful use of itraconazole in a closely related species (A. muletensis), our results show that these antifungal treatments are not always effective and that full clearance of animals cannot be assumed following treatment.


Subject(s)
Anura/microbiology , Chytridiomycota , Itraconazole/therapeutic use , Mycoses/veterinary , Thiophanate/therapeutic use , Animals , Antifungal Agents/therapeutic use , Larva/microbiology , Mycoses/drug therapy , Mycoses/microbiology
2.
Vet Parasitol ; 75(2-3): 191-7, 1998 Feb 28.
Article in English | MEDLINE | ID: mdl-9637220

ABSTRACT

The anthelmintic efficacy of benzimidazoles, levamisole, rafoxanide and ivermectin was evaluated on an institutional farm in Kenya using faecal egg count reduction test, larval cultures and a controlled slaughter trial. The results of this study indicated simultaneous resistance of Haemonchus contortus against benzimidazoles, levamisole and rafoxanide and Trichostrongylus columbriformis and Oesophagostomum sp. against levamisole on the same farm. Injectable and orally administered ivermectin was effective against the benzimidazole and levamisole resistant H. contortus.


Subject(s)
Antinematodal Agents/pharmacology , Drug Resistance, Multiple , Goat Diseases/drug therapy , Oesophagostomum/drug effects , Strongylida Infections/veterinary , Trichostrongyloidea/drug effects , Albendazole/pharmacology , Albendazole/therapeutic use , Animals , Antinematodal Agents/therapeutic use , Feces/parasitology , Female , Goat Diseases/parasitology , Goats , Haemonchus/drug effects , Ivermectin/pharmacology , Ivermectin/therapeutic use , Kenya , Levamisole/pharmacology , Levamisole/therapeutic use , Male , Parasite Egg Count/veterinary , Rafoxanide/pharmacology , Rafoxanide/therapeutic use , Random Allocation , Strongylida Infections/drug therapy , Strongylida Infections/parasitology , Thiophanate/pharmacology , Thiophanate/therapeutic use
3.
Vet Res Commun ; 21(7): 483-91, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9345715

ABSTRACT

Multiple resistance to albendazole, thiophanate, levamisole and orally administered invermectin was detected in an isolate of Haemonchus contortus in sheep on a farm where benzimidazole resistance had already been identified. Following a faecal egg count reduction test, this was confirmed by both critical and controlled anthelmintic tests. Different groups of sheep infected naturally or given an experimental infection with the benzimidazole-resistant isolate were treated with the recommended doses of various anthelmintics. Compared to the control group, the percentage reductions in the faecal egg counts of sheep treated with albendazole, thiophanate, levamisole and ivermectin varied between 38.2% and 79.1% and the residual worm counts between 27.3% and 57.5%. The results indicate the presence of multiple anthelmintic resistance in this isolate of H. contortus. Sheep treated with closantel showed 100% reductions in faecal egg and worm counts, indicating that this drug was very effective against the population of H. contortus on the farm.


Subject(s)
Anthelmintics/therapeutic use , Drug Resistance, Multiple , Haemonchiasis/veterinary , Haemonchus/drug effects , Sheep Diseases/drug therapy , Administration, Oral , Albendazole/administration & dosage , Albendazole/pharmacology , Albendazole/therapeutic use , Animals , Anthelmintics/administration & dosage , Anthelmintics/pharmacology , Benzimidazoles/administration & dosage , Benzimidazoles/pharmacology , Benzimidazoles/therapeutic use , Dose-Response Relationship, Drug , Feces/parasitology , Haemonchiasis/drug therapy , Haemonchiasis/epidemiology , Haemonchus/isolation & purification , Ivermectin/administration & dosage , Ivermectin/pharmacology , Ivermectin/therapeutic use , Kenya/epidemiology , Levamisole/administration & dosage , Levamisole/pharmacology , Levamisole/therapeutic use , Parasite Egg Count/veterinary , Salicylanilides/administration & dosage , Salicylanilides/pharmacology , Salicylanilides/therapeutic use , Sheep , Sheep Diseases/epidemiology , Thiophanate/administration & dosage , Thiophanate/pharmacology , Thiophanate/therapeutic use
5.
Trop Anim Health Prod ; 28(3): 216-20, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8888527

ABSTRACT

Forty-nine sheep artificially exposed to a thiabendazole (TBZ) resistant isolate of Haemonchus contortus were assigned to 7 groups of 7 animals each and used to conduct a controlled anthelmintic trial. One group of sheep served as untreated infected controls and 6 groups were treated as follows: closantel, 5.0 mg kg-1; ivermectin, 0.2 mg kg-1; oxfendazole, 5.0 mg kg-1; thiophanate, 50 mg kg-1, levamisole, 7.5 mgkg-1 and thiabendazole, 66 mg kg-1. Eggs per gram of faeces were determined on days 21, 24 and day 34 (10 days post-treatment) after infection and all animals were necropsied for residual worm counts. The calculated efficacies of the treatments against H. contortus as indicated by worm reduction were closantel (100%), ivermectin (99.3%), oxfendazole (35.2%), thiophanate (56.7%), levamisole (98.6%) and thiabendazole (24.3%). The data therefore indicate that the TBZ-resistant isolate of H. contortus used was highly resistant to the 2 benzimidazole (BZ) anthelmintics, oxfendazole and thiophanate. This is the first report in Kenya of a field strain of H. contortus resistant to thiophanate.


Subject(s)
Anthelmintics/therapeutic use , Benzimidazoles/therapeutic use , Haemonchiasis/veterinary , Ivermectin/therapeutic use , Levamisole/therapeutic use , Salicylanilides/therapeutic use , Sheep Diseases , Thiabendazole/therapeutic use , Thiophanate/therapeutic use , Animals , Drug Resistance , Feces/parasitology , Female , Haemonchiasis/drug therapy , Male , Parasite Egg Count , Sheep
6.
Vet Parasitol ; 36(1-2): 21-6, 1990 May.
Article in English | MEDLINE | ID: mdl-2382387

ABSTRACT

Following reports of suspected gastrointestinal strongylid nematode resistance to thiophanate in sheep and goats at Sokoine University of Agriculture (SUA), Tanzania, field strains of Haemonchus contortus, one from SUA and another from Kimamba, Tanzania, were selected for a critical controlled test to evaluate the efficacy of thiophanate. The SUA H. contortus strain in goats showed a marked resistance to thiophanate at an oral dose of 50 mg kg-1 liveweight (efficacy = 24.1%), while the Kimamba H. contortus strain showed very marked susceptibility (efficacy = 99.7%) to thiophanate at the same oral dose. This is the first report from East Africa of a field strain of H. contortus resistant to thiophanate. The incidence of resistant strains of strongyloid parasites to benzimidazole anthelmintics in sheep and goats in East Africa is on the increase. The magnitude of this problem should be evaluated and remedial solutions sought.


Subject(s)
Carbamates/pharmacology , Goat Diseases/parasitology , Haemonchiasis/veterinary , Haemonchus/drug effects , Thiophanate/pharmacology , Trichostrongyloidea/drug effects , Trichostrongyloidiasis/veterinary , Abomasum/parasitology , Animals , Drug Resistance , Feces/parasitology , Female , Goat Diseases/drug therapy , Goats , Haemonchiasis/drug therapy , Haemonchiasis/parasitology , Parasite Egg Count/veterinary , Random Allocation , Tanzania , Thiophanate/therapeutic use
7.
Vet Parasitol ; 35(1-2): 139-45, 1990 Feb.
Article in English | MEDLINE | ID: mdl-2343524

ABSTRACT

The anthelmintic efficacy of thiophanate and albendazole was compared in sheep with heavy infestations of Dicrocoelium dentriticum. The effectiveness of each drug was determined by counting the numbers of D. dentriticum in animals killed 21 days after treatment. In one group, the dose of thiophanate recommended for use against gastrointestinal (GI) nematodes (50 mg kg-1 live weight) was found to be 74.4% effective against D. dentriticum. Two tablets (each containing 76 mg of active ingredient) of albendazole per 30 kg live weight were given to a second group and the dose repeated after 1 week. Under this regime, albendazole was found to be 12.7% effective against D. dentriticum. The effect of each drug on other parasites was as follows; thiophanate had no effect against Fasciola hepatica or cestodes, while albendazole was 71.5% effective against F. hepatica and 100% effective against cestodes. Both drugs were highly effective against GI nematodes.


Subject(s)
Albendazole/therapeutic use , Carbamates/therapeutic use , Dicrocoeliasis/veterinary , Helminthiasis, Animal , Sheep Diseases/drug therapy , Thiophanate/therapeutic use , Animals , Cestode Infections/drug therapy , Cestode Infections/veterinary , Dicrocoeliasis/drug therapy , Fasciola hepatica , Fascioliasis/drug therapy , Fascioliasis/veterinary , Feces/parasitology , Female , Helminthiasis/drug therapy , Nematode Infections/drug therapy , Nematode Infections/veterinary , Parasite Egg Count/veterinary , Sheep
8.
Trop Anim Health Prod ; 22(1): 1-6, 1990 Feb.
Article in English | MEDLINE | ID: mdl-2321258

ABSTRACT

Investigations were conducted in naturally infected goats to determine the main epidemiological factors related to gastro-intestinal nematode infections in southern Tanzania with a view to making appropriate recommendations for control. Faecal worm egg counts rose during the single rainy season and then fell to remain low during the dry season. The beneficial effect of an anthelmintic treatment after the rains was demonstrated in weaner goats under traditional management and this should form the basis of rational control.


Subject(s)
Carbamates/therapeutic use , Goat Diseases/epidemiology , Helminthiasis, Animal , Intestinal Diseases, Parasitic/veterinary , Thiophanate/therapeutic use , Animals , Feces/parasitology , Female , Goat Diseases/prevention & control , Goats , Helminthiasis/epidemiology , Helminthiasis/prevention & control , Intestinal Diseases, Parasitic/epidemiology , Intestinal Diseases, Parasitic/prevention & control , Male , Parasite Egg Count/veterinary , Rain , Seasons , Tanzania/epidemiology , Weight Gain
10.
Ann Rech Vet ; 19(2): 119-22, 1988.
Article in French | MEDLINE | ID: mdl-3415190

ABSTRACT

After a single oral dosage of 40 mg thiophanate/kg in cattle, sheep and goats, the parent compound and its main metabolite: ethyl benzimidazol-1H-yl-2-carbamate (EBC) are evidenced in plasma by HPLC analysis for 60 to 72 hours. The rate of metabolic change of thiophanate into EBC is 34% in sheep, 52% in goats and 57% in cattle. At this dosage, thiophanate seems to be effective against Dicrocoelium in sheep. On the contrary, EBC is uneffective at 15 mg/kg while it seems undetectable in plasma at any time.


Subject(s)
Benzimidazoles/metabolism , Carbamates/pharmacokinetics , Dicrocoeliasis/veterinary , Ruminants/parasitology , Thiophanate/pharmacokinetics , Animals , Benzimidazoles/blood , Cattle , Cattle Diseases/blood , Cattle Diseases/drug therapy , Cattle Diseases/parasitology , Dicrocoeliasis/drug therapy , Female , Goats/parasitology , Ruminants/blood , Sheep , Sheep Diseases/blood , Sheep Diseases/drug therapy , Sheep Diseases/parasitology , Thiophanate/blood , Thiophanate/therapeutic use
11.
Vet Q ; 6(1): 27-30, 1984 Jan.
Article in English | MEDLINE | ID: mdl-6375107

ABSTRACT

Studies on the efficacy in pigs of low level in-feed medication with the anthelmintic thiophanate at a minimum intake of 6 mg/kg/day for fourteen days are reported. A trial was conducted to compare a group of medicated fattening pigs with a similar unmedicated group on premises known to have a high challenge of Ascaris spp. Daily growth rate was improved whilst feed conversion ratio and the liver condemnation rate were reduced in the treatment group. Routine medication of a whole herd using this regime contributed to a great improvement of the herd production when assessed by the above criteria. User studies in various geographical areas of the Netherlands involving 1500 adult pigs and 1200 fattening pigs medicated with thiophanate in-feed for fourteen days demonstrated that the compound eliminated the faecal worm egg output and was readily accepted and tolerated by pigs.


Subject(s)
Anthelmintics/administration & dosage , Ascariasis/veterinary , Carbamates/administration & dosage , Swine Diseases/drug therapy , Thiophanate/administration & dosage , Animal Feed , Animals , Anthelmintics/therapeutic use , Ascariasis/drug therapy , Clinical Trials as Topic , Female , Male , Netherlands , Swine , Thiophanate/therapeutic use
13.
Res Vet Sci ; 29(3): 370-2, 1980 Nov.
Article in English | MEDLINE | ID: mdl-7255897

ABSTRACT

The occurrence of a field strain of Haemonchus contortus which was resistant to thiophanate and susceptible to thiabendazole and levamisole is reported. The LD95 of thiophanate for the strain was found to be 156.1 mg/kg and its resistance factor was 6.7. In possessing specific thiophanate resistance it differed from previously reported thiophanate resistant strains of H contortus which have been benzimidazole resistant worms that have possessed cross resistance to thiophanate.


Subject(s)
Carbamates/pharmacology , Haemonchiasis/veterinary , Haemonchus/drug effects , Thiophanate/pharmacology , Trichostrongyloidea/drug effects , Trichostrongyloidiasis/veterinary , Animals , Drug Resistance , Feces/parasitology , Haemonchiasis/drug therapy , Haemonchiasis/parasitology , Levamisole/therapeutic use , Male , Sheep , Sheep Diseases/drug therapy , Sheep Diseases/parasitology , Thiabendazole/therapeutic use , Thiophanate/therapeutic use
19.
Res Vet Sci ; 25(2): 251-2, 1978 Sep.
Article in English | MEDLINE | ID: mdl-725340

ABSTRACT

In a trial with natural infections of trichostrongyles in sheep, thiophanate and thiabendazole at 100 mg/kg and 200 mg/kg bodyweight were highly effective in removing all stages of development of the helminths including the inhibited stages. At 50 mg/kg bodyweight however, both drugs were only capable of reducing helminth load.


Subject(s)
Carbamates/therapeutic use , Sheep Diseases/drug therapy , Thiabendazole/therapeutic use , Thiophanate/therapeutic use , Trichostrongyloidiasis/veterinary , Trichostrongylosis/veterinary , Animals , Sheep , Trichostrongyloidea/growth & development , Trichostrongylosis/drug therapy
20.
Vet Rec ; 103(7): 131-4, 1978 Aug 12.
Article in English | MEDLINE | ID: mdl-695254

ABSTRACT

Thiophanate administered daily at low dosages reduced nematode faecal egg output, egg hatchability and parasitic worm burdens in treated lambs and ewes. Six daily doses of 1 or 3 mg per kg thiophanate (approximately 1/25th to 1/75th of the median therapeutic dose), given to lambs experimently infected with Trichostrongylus colubriformis, were partially effective in suppressing faecal egg output and egg hatchability. Six doses of 5 mg per kg per day were effective in lambs infected with Haemonchus contortus and Nematodirus spathiger. Daily doses of thiophanate (50 or 200 mg per head) given over 14 weeks to lambs grazing contaminated pasture resulted in improved productivity (the higher dosage) and suppression of output of viable eggs and reduced worm burdens (both dosages). Reduced output of viable eggs was also obtained in housed, lactating ewes receiving 5 or 7 mg per kg thiophanate dispersed daily in the feed for 11 or nine weeks respectively after lambing.


Subject(s)
Antinematodal Agents/administration & dosage , Carbamates/administration & dosage , Sheep Diseases/drug therapy , Thiophanate/administration & dosage , Trichostrongyloidiasis/veterinary , Animals , Antinematodal Agents/therapeutic use , Haemonchiasis/drug therapy , Haemonchiasis/veterinary , Ostertagiasis/drug therapy , Ostertagiasis/veterinary , Sheep , Thiophanate/therapeutic use , Trichostrongyloidiasis/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...